GWM
ALKS icon

Geneos Wealth Management’s Alkermes ALKS Stock Holding History

Geneos Wealth Management’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-203
Closed -$5.81K – 2494
2025
Q2 		$5.81K Buy
203
+2
+1% +$60 ﹤0.01% 2528
2025
Q1 		$6.64K Buy
201
+149
+287% +$4.86K ﹤0.01% 2417
2024
Q4 		$1.5K Hold
52
– – ﹤0.01% 2678
2024
Q3 		$1.46K Buy
+52
New +$1.39K ﹤0.01% 2368
2018
Q1 		– Sell
-25
Closed -$1K – 2167
2017
Q4 		$1K Hold
25
– – ﹤0.01% 2080
2017
Q3 		$1K Hold
25
– – ﹤0.01% 2025
2017
Q2 		$1K Hold
25
– – ﹤0.01% 1976
2017
Q1 		$1K Hold
25
– – ﹤0.01% 1956
2016
Q4 		$1K Hold
25
– – ﹤0.01% 1920
2016
Q3 		$1K Buy
+25
New +$1.19K ﹤0.01% 1844

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geneos Wealth Management's ALKS Position: Q3 2025 in Review

Geneos Wealth Management sold out of Alkermes (ALKS) in Q3 2025, closing a stake of 203 shares — an estimated $5.81K sold.

Geneos Wealth Management first reported a position in ALKS in Q3 2016 and held it in 10 quarters. The position peaked at $6.64K in Q1 2025. 358 funds tracked by Wall St. Rank hold ALKS as of Q3 2025.

  • Geneos Wealth Management reported no remaining Alkermes position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 203 Alkermes shares in Q3 2025, an estimated $5.81K.
  • Geneos Wealth Management first reported a position in Alkermes in Q3 2016 and held it in 10 quarters.
  • Geneos Wealth Management's Alkermes position peaked at $6.64K in Q1 2025.
  • 358 funds tracked by Wall St. Rank held Alkermes as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.